CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

British biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron ...

The UK government recently asked all secondary schools to provide on-site COVID-19 testing for pupils, and advised secondary, college and university students to continue twice weekly testing, in an ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

Add Yahoo as a preferred source to see more of our stories on Google. There are three different ways to test for COVID-19: PCR tests, antigen tests and antibody tests. Each method is best for a ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

The proportion of people with current COVID-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Polymerase chain reaction (PCR) and rapid (antigen) tests for COVID-19 both involve taking a swab. Results for a PCR test take longer, as it needs to go to a laboratory. It is more costly but tends to ...

New York, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028 ...

Avacta to replace antibodies in AffiDX test Finds test is less sensitive to Omicron at lower viral loads No timeline for sales resumption, shares plunge 26.5% Jan 10 (Reuters) - Britain's Avacta Group ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. In work published in Cell Reports Medicine, a team of researchers from the ...